

P R O D U C T IO N O F B IO A C T IV E S U B S T A N C E S B Y U N C O N V E N T IO N A L
TE C H N O LO G IE S
GINSENG,ADAPTOGENICSANDXXICENTURY:FROMSTRAINSTO
FINISHEDPRODUCTS
L.I.Slepyan
ChemicalPharmaceuticalAcademy, St.-Petersburg, Russia.
Ginseng ( Panax Ginseng C.A. Mey.) is relict plant, which miraculous
properties were famous in the Eastern over 4000 years ago. Academic N.V.
Lazarev named these plants as adaptogen. Its must be to increase the
human body’s capacity to adapt of the abnormal physical, chemical and
other environmental factors and have not action in normal. Ginseng has
been confessed as one of the best natural adaptogen. The World Health
Organization consider that adaptogenes would play the important role in the
profilaxis of many diseases and preservation of health from stress.
From 1965 to 1985 years different strains of tissue culture of Panax
ginseng, P. guinguefolius L., Polyscias filicifolius Bailey, and some selective
strains o f
Ginseng
with original y-interferon inducer had been received. The
new plants adaptogenes have been prepared from these strains by
biothechnology. All remedies are defended by Russian Patents and have
ratify documents. Its may be used as the medical remedies and as the
addition for foods.
Bioginseng - the new plant adaptogen, which has been received from
strain o f
Ginseng.
It has all aspects of pharmacological actions as the
remedies from natural Ginseng roots.
Panaxel - the new plant adaptogen, which has been received from
selective strain o f
Ginseng.
It contains the special inducer of y-interferon
and possess the w ide spectrum of immunological actions and also
anticancerogenical effects.
Panasorb - new plant absorbent which has been prepared from
biomasses o f plant cells of the strains o f
Ginseng.
Panasorb consist of the
microelements, pectin, cellulose and can to absorb the heavy metals and
cholesterol.
All these preparations have been tested in many clinics and have positive
results. The biotechnology of the different strains of
Araiiaceae
to open the
new fundamental base in pharmaceutical industry fo r receiving the new
preparations for health.
507
Научная электронная библиотека ЦНСХБ